Advanced

Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe.

Luca, Bogdan LU ; Darenberg, Jessica; Neal, Shona; Siljander, Tuula; Strakova, Lenka; Tanna, Asha; Creti, Roberta; Ekelund, Kim; Koliou, Maria and Tassios, Panayotis T, et al. (2009) In Journal of Clinical Microbiology 47. p.1155-1165
Abstract
In an attempt to compare the epidemiology of severe S. pyogenes infection within Europe, prospective data were collected through the Strep-EURO programme. Surveillance of severe S. pyogenes infection diagnosed during 2003 and 2004 was undertaken in eleven countries across Europe using a standardised case definition and questionnaire. Patient data as well as bacterial isolates were collected and characterized by T- and, M/emm-typing and selected strains were analysed for presence of superantigen genes. Data were analysed to compare the clinical and microbiological patterns of infections across participating countries. Totally 4353 isolates were collected from 5521 cases with severe S. pyogenes infection identified. It was wide diversity of... (More)
In an attempt to compare the epidemiology of severe S. pyogenes infection within Europe, prospective data were collected through the Strep-EURO programme. Surveillance of severe S. pyogenes infection diagnosed during 2003 and 2004 was undertaken in eleven countries across Europe using a standardised case definition and questionnaire. Patient data as well as bacterial isolates were collected and characterized by T- and, M/emm-typing and selected strains were analysed for presence of superantigen genes. Data were analysed to compare the clinical and microbiological patterns of infections across participating countries. Totally 4353 isolates were collected from 5521 cases with severe S. pyogenes infection identified. It was wide diversity of M/emm-types (104) found among the S. pyogenes clinical isolates but M/emm-type distribution varied broadly between participating countries. The ten most predominant M/emm-types were 1, 28, 3, 89, 87, 12, 4, 83, 81, and 5 in descending order. A correlation was found between some specific disease manifestation, age of patients and emm-types. Streptococcal toxic shock syndrome and necrotizing fasciitis, although caused by a large number of types, were particularly associated with M/emm-types 1 and 3. The emm-types included in the 26-valent vaccine under development, were generally well represented in the presentmaterial; 16 of the vaccine types accounted for 69% of isolates. The Strep-EURO collaborative programme has contributed to enhance the knowledge on the spread of invasive disease caused by S. pyogenes within Europe and encourage future surveillance with notification of cases and characterisation of strains, important for vaccine strategies and other health care issues. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Microbiology
volume
47
pages
1155 - 1165
publisher
American Society for Microbiology
external identifiers
  • WOS:000264797000041
  • PMID:19158266
  • Scopus:65249093620
ISSN
1098-660X
DOI
10.1128/JCM.02155-08
language
English
LU publication?
yes
id
e2e0642a-596d-4fa1-b840-2572a190bf12 (old id 1289432)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/19158266?dopt=Abstract
date added to LUP
2009-02-04 12:41:53
date last changed
2016-11-06 04:25:10
@misc{e2e0642a-596d-4fa1-b840-2572a190bf12,
  abstract     = {In an attempt to compare the epidemiology of severe S. pyogenes infection within Europe, prospective data were collected through the Strep-EURO programme. Surveillance of severe S. pyogenes infection diagnosed during 2003 and 2004 was undertaken in eleven countries across Europe using a standardised case definition and questionnaire. Patient data as well as bacterial isolates were collected and characterized by T- and, M/emm-typing and selected strains were analysed for presence of superantigen genes. Data were analysed to compare the clinical and microbiological patterns of infections across participating countries. Totally 4353 isolates were collected from 5521 cases with severe S. pyogenes infection identified. It was wide diversity of M/emm-types (104) found among the S. pyogenes clinical isolates but M/emm-type distribution varied broadly between participating countries. The ten most predominant M/emm-types were 1, 28, 3, 89, 87, 12, 4, 83, 81, and 5 in descending order. A correlation was found between some specific disease manifestation, age of patients and emm-types. Streptococcal toxic shock syndrome and necrotizing fasciitis, although caused by a large number of types, were particularly associated with M/emm-types 1 and 3. The emm-types included in the 26-valent vaccine under development, were generally well represented in the presentmaterial; 16 of the vaccine types accounted for 69% of isolates. The Strep-EURO collaborative programme has contributed to enhance the knowledge on the spread of invasive disease caused by S. pyogenes within Europe and encourage future surveillance with notification of cases and characterisation of strains, important for vaccine strategies and other health care issues.},
  author       = {Luca, Bogdan and Darenberg, Jessica and Neal, Shona and Siljander, Tuula and Strakova, Lenka and Tanna, Asha and Creti, Roberta and Ekelund, Kim and Koliou, Maria and Tassios, Panayotis T and van der Linden, Mark and Straut, Monica and Vuopio-Varkila, Jaana and Bouvet, Anne and Efstratiou, Androulla and Schalén, Claës and Henriques-Normark, Birgitta and Jasir, Aftab},
  issn         = {1098-660X},
  language     = {eng},
  pages        = {1155--1165},
  publisher    = {ARRAY(0x8210b10)},
  series       = {Journal of Clinical Microbiology},
  title        = {Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe.},
  url          = {http://dx.doi.org/10.1128/JCM.02155-08},
  volume       = {47},
  year         = {2009},
}